- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/11 - DNA or RNA fragments; Modified forms thereof
Patent holdings for IPC class C12N 15/11
Total number of patents in this class: 16608
10-year publication summary
|
669
|
725
|
799
|
1070
|
1179
|
1309
|
1430
|
1550
|
1522
|
1086
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19182 |
465 |
| Massachusetts Institute of Technology | 9837 |
289 |
| President and Fellows of Harvard College | 5838 |
260 |
| The Broad Institute, Inc. | 1638 |
260 |
| Alnylam Pharmaceuticals, Inc. | 1099 |
192 |
| Ionis Pharmaceuticals, Inc. | 798 |
189 |
| University of Massachusetts | 2139 |
158 |
| The Board of Trustees of the Leland Stanford Junior University | 6114 |
141 |
| The General Hospital Corporation | 4575 |
138 |
| The Trustees of the University of Pennsylvania | 4185 |
109 |
| Duke University | 2921 |
95 |
| CRISPR Therapeutics AG | 367 |
89 |
| The Johns Hopkins University | 5428 |
88 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 301 |
87 |
| City of Hope | 946 |
86 |
| University of Vienna | 109 |
85 |
| Monsanto Technology LLC | 8100 |
84 |
| Pioneer Hi-Bred International, Inc. | 6313 |
79 |
| Modernatx, Inc. | 1220 |
79 |
| Dicerna Pharmaceuticals, Inc. | 282 |
78 |
| Other owners | 13557 |